DGAP-News: PULSION Medical Systems AG presents future products 'PulsioFlex(TM) ' and '

DGAP-News: PULSION Medical Systems AG presents future products 'PulsioFlex(TM) ' and 'ProAQT'

ID: 17191

(firmenpresse) - PULSION Medical Systems AG / Miscellaneous/Miscellaneous

09.03.2010 12:02

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Flexible monitoring platform 'PulsioFlex(TM)' and 'ProAQT' - minimal
invasive cardio-vascular monitoring for high risk patients - presented


Munich, March 9th 2010 - PULSION Medical Systems AG, a life-science
corporation specializing in medical diagnosis and therapy systems, which is
noted in the Prime Standard segment at the Frankfurt Stock Exchange,
presents the new product lines 'PulsioFlex(TM)' and ProAQT' at the 30th
ISICEM in Brussels, one of the biggest congresses for intensive care
medicine and emergency medicine worldwide.

PulsioFlex(TM) represents next to the PiCCO2(R) a second but smaller
PULSION monitoring platform, which can not only be used in ICUs, but also
in other critical care environments within the hospital, e.g. at the
emergency department or in the operating room. The combination of current
and future PULSION technologies will be possible due to the extraordinary
flexible concept. This also allows marketing the PulsioFlex(TM) as a
stand-alone monitor for two of the other PULSION monitoring technologies -
the PulsioFlex(TM) will completely replace the CeVOX- and LiMON devices.

Beside the well known PULSION monitoring technologies there will also be a
new technology available for minimally invasive 'calibrationless' trending
of the cardiovascular system. This easy to use monitoring method - ProAQT
(Professional Advanced Flow Trending) - is especially for use in
hemodynamically stable high risk patients. PULSION's PiCCO technology
remains the monitoring of choice in hemodynamically unstable patients.





With this development PULSION significantly and fundamentally amends and
expands its product range in hemodynamic monitoring. The current very
successful business model will be expanded and in the near future numerous
technological enhancements will be realised with and through the new
platform.

By just changing the modules the flexible availability of the different
monitoring technologies creates the ability to always use monitoring tailor
made for the patient and the level of severity of his or her disease. The
new slogan 'PulsioFlex(TM) - patient centered flexibility' reflects this
philosophy.

'The presentation of our two new future products PulsioFlex(TM) and ProAQT
adds two more pieces to complete our product portfolio to enable doctors
and health professionals to use comprehensive and individualized monitoring
of critically ill patients in any situation. We are going to expand this
range of products further in the near future to ease and speed up
therapeutic decision making to the advantage of our patients', says
Christoph Manegold, member of the board and Head of R&D of PULSION Medical
Systems AG.


09.03.2010 12:02 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------

Language: English
Company: PULSION Medical Systems AG
Joseph-Wild-Strasse 20
81829 München
Deutschland
Phone: +49 (0)89 4599 14-0
Fax: +49 (0)89 4599 14-18
E-mail: info(at)pulsion.com
Internet: www.pulsion.com
ISIN: DE0005487904
WKN: 548790
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehrin Berlin, München, Düsseldorf, Hamburg, Stuttgart

End of News DGAP News-Service

---------------------------------------------------------------------------

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
Datum: 09.03.2010 - 12:02 Uhr
Sprache: Deutsch
News-ID 17191
Anzahl Zeichen: 0

contact information:

Kategorie:

Business News



Diese Pressemitteilung wurde bisher 480 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DGAP-News: PULSION Medical Systems AG presents future products 'PulsioFlex(TM) ' and 'ProAQT'"
steht unter der journalistisch-redaktionellen Verantwortung von

PULSION Medical Systems AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

DGAP-News: PULSION and Mindray sign Licensing Agreement ...

PULSION Medical Systems AG / Agreement/Agreement 31.05.2010 15:51 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ----------- ...

Alle Meldungen von PULSION Medical Systems AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z